{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:10:22Z","timestamp":1778879422411,"version":"3.51.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.expneurol.2025.115355","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T11:11:00Z","timestamp":1750677060000},"page":"115355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pathogenic role of CD169+ macrophages in neuronal loss and motor decline in NMO mice"],"prefix":"10.1016","volume":"392","author":[{"given":"Yuko","family":"Morita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwaseun","family":"Fatoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahide","family":"Itokazu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihide","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2025.115355_bb0005","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00401-013-1204-8","article-title":"Unique neuromyelitis optica pathology produced in na\u00efve rats by intracerebral administration of NMO-IgG","volume":"127","author":"Asavapanumas","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2025.115355_bb0010","doi-asserted-by":"crossref","DOI":"10.1080\/14712598.2021.1884223","article-title":"Targeting the complement system in neuromyelitis optica spectrum disorder","author":"Asavapanumas","year":"2021","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.expneurol.2025.115355_bb0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jneuroim.2012.09.010","article-title":"Complement-dependent pathogenicity of brain-specific antibodies in cerebrospinal fluid","volume":"254","author":"Asgari","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2025.115355_bb0025","doi-asserted-by":"crossref","first-page":"E1738","DOI":"10.1073\/pnas.1525528113","article-title":"New tools for studying microglia in the mouse and human CNS","volume":"113","author":"Bennett","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2025.115355_bb0030","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/1352458517698759","article-title":"CD169 is a marker for highly pathogenic phagocytes in multiple sclerosis","volume":"24","author":"Bogie","year":"2018","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.expneurol.2025.115355_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102538","article-title":"Review of approved NMO therapies based on mechanism of action, efficacy and long-term effects","author":"Brod","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.expneurol.2025.115355_bb0040","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrn3710","article-title":"Microglial phagocytosis of live neurons","volume":"15","author":"Brown","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115355_bb0045","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.15327","article-title":"Microglial phagocytosis of neurons in neurodegeneration, and its regulation","author":"Butler","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2025.115355_bb0050","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.neuroscience.2011.11.016","article-title":"The grid-walking test: assessment of sensorimotor deficits after moderate or severe dopamine depletion by 6-hydroxydopamine lesions in the dorsal striatum and medial forebrain bundle","volume":"202","author":"Chao","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2025.115355_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00263","article-title":"Much more than M1 and M2 macrophages, there are also CD169+ and TCR+ macrophages","author":"Ch\u00e1vez-Gal\u00e1n","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.expneurol.2025.115355_bb0060","first-page":"4025","article-title":"Astrocyte-microglia interaction drives evolving neuromyelitis optica lesion","volume":"140","author":"Chen","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2025.115355_bb0065","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.12793","article-title":"Experimental animal models of aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders: progress and shortcomings","author":"Duan","year":"2020","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2025.115355_bb0070","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12974-020-01874-6","article-title":"Tanshinone IIA alleviates brain damage in a mouse model of neuromyelitis optica spectrum disorder by inducing neutrophil apoptosis","volume":"17","author":"Gong","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2025.115355_bb0075","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1002\/pmic.201400431","article-title":"High-resolution quantitative proteome analysis reveals substantial differences between phagosomes of RAW 264.7 and bone marrow derived macrophages","volume":"15","author":"Guo","year":"2015","journal-title":"Proteomics"},{"key":"10.1016\/j.expneurol.2025.115355_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.979373","article-title":"Myeloid CD169\/Siglec1: an immunoregulatory biomarker in viral disease","author":"Herzog","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.expneurol.2025.115355_bb0085","first-page":"77","article-title":"The binding property of a monoclonal antibody against the extracellular domains of aquaporin-4 directs aquaporin-4 toward endocytosis","volume":"7","author":"Huang","year":"2016","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.expneurol.2025.115355_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1423107","article-title":"Scientific issues with rodent models of neuromyelitis optic spectrum disorders","volume":"15","author":"Huang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.expneurol.2025.115355_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-021-02232-w","article-title":"Anti-AQP4 autoantibodies promote ATP release from astrocytes and induce mechanical pain in rats","volume":"18","author":"Ishikura","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2025.115355_bb0100","series-title":"RGMa Signal in Macrophages Induces Neutrophil-Related Astrocytopathy in NMO","first-page":"532","volume":"91","author":"Iwamoto","year":"2022"},{"key":"10.1016\/j.expneurol.2025.115355_bb0105","article-title":"Monoclonal antibody therapies for multiple sclerosis and neuromyelitis optica spectrum disorder","author":"Kim","year":"2020","journal-title":"J. Clin. Neurol. (Korea)"},{"key":"10.1016\/j.expneurol.2025.115355_bb0110","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1177\/1352458510376640","article-title":"Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity","volume":"16","author":"Kim","year":"2010","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.expneurol.2025.115355_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/735486","article-title":"Brain abnormalities in neuromyelitis optica spectrum disorder","volume":"2012","author":"Kim","year":"2012","journal-title":"Mult. Scler. Int."},{"key":"10.1016\/j.expneurol.2025.115355_bb0120","article-title":"Early involvement of peripherally derived monocytes in inflammation in an NMO-like mouse model","volume":"14","author":"Kim","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2025.115355_bb0125","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/WNO.0000000000000102","article-title":"The treatment of neuromyelitis optica","volume":"34","author":"Kowarik","year":"2014","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.expneurol.2025.115355_bb0130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/ni.1990","article-title":"IRF5 promotes inflammatory macrophage polarization and T H1-TH17 responses","volume":"12","author":"Krausgruber","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.expneurol.2025.115355_bb0135","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s40478-015-0259-2","article-title":"Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody","volume":"3","author":"Kurosawa","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.expneurol.2025.115355_bb0140","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2025.115355_bb0145","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2025.115355_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-023-00382-w","article-title":"Metabolic regulation of microglial phagocytosis: implications for Alzheimer\u2019s disease therapeutics","author":"Lepiarz-Raba","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.expneurol.2025.115355_bb0155","article-title":"CD169 expressing macrophage, a key subset in mesenteric lymph nodes promotes mucosal inflammation in dextran sulfate sodium-induced colitis","volume":"8","author":"Li","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.expneurol.2025.115355_bb0160","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.7150\/ijms.61153","article-title":"The role and mechanisms of microglia in neuromyelitis optica spectrum disorders","volume":"18","author":"Li","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.expneurol.2025.115355_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2798","article-title":"Microglial\/macrophage activation in the cerebrospinal fluid of neuromyelitis optica spectrum disorders","volume":"12","author":"Li","year":"2022","journal-title":"Brain Behav."},{"key":"10.1016\/j.expneurol.2025.115355_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/br.2020.1402","article-title":"Functions of cd169 positive macrophages in human diseases (review)","volume":"14","author":"Liu","year":"2020","journal-title":"Biomed. Rep."},{"issue":"Pt 7","key":"10.1016\/j.expneurol.2025.115355_bb0175","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica HHS public access","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2025.115355_bb0180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/bpa.12099","article-title":"The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica","author":"Lucchinetti","year":"2014","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2025.115355_bb0185","series-title":"The Changing Phenotype of Microglia from Homeostasis to Disease","author":"Luo","year":"2012"},{"key":"10.1016\/j.expneurol.2025.115355_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577387","article-title":"NMOSD acute attack: understanding, treatment and innovative treatment prospect","author":"Ma","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2025.115355_bb0195","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis","volume":"130","author":"Misu","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2025.115355_bb0200","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-022-02623-7","article-title":"A novel aquaporin-4-associated optic neuritis rat model with severe pathological and functional manifestations","volume":"19","author":"Morita","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.expneurol.2025.115355_bb0205","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/jlb.66.5.705","article-title":"Sialic acid binding receptors (siglecs) expressed by macrophages","volume":"66","author":"Munday","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.expneurol.2025.115355_bb0210","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/jnnp-2011-300403","article-title":"Clinical features of neuromyelitis optica in a large Japanese cohort: comparison between phenotypes","volume":"82","author":"Nagaishi","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2025.115355_bb0215","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jneuroim.2003.12.010","article-title":"CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis","volume":"149","author":"Narikawa","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2025.115355_bb0220","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.4049\/jimmunol.1003600","article-title":"Inhibition of microglial phagocytosis is sufficient to prevent inflammatory neuronal death","volume":"186","author":"Neher","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2025.115355_bb0225","doi-asserted-by":"crossref","first-page":"39904","DOI":"10.1074\/jbc.M111.267583","article-title":"Neuronal death induced by nanomolar amyloid \u03b2 is mediated by primary phagocytosis of neurons by microglia","volume":"286","author":"Neniskyte","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2025.115355_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01084","article-title":"Macrophage polarization: different gene signatures in M1(Lps+) vs. classically and M2(LPS-) vs. alternatively activated macrophages","author":"Orecchioni","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.expneurol.2025.115355_bb0235","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-89786-0","article-title":"SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of multiple sclerosis patients","volume":"11","author":"Ostendorf","year":"2021","journal-title":"Sci. Rep."},{"issue":"Pt 1","key":"10.1016\/j.expneurol.2025.115355_bb0240","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1242\/jcs.101.1.201","article-title":"The blood-brain barrier regulates the expression of a macrophage sialic acid-binding receptor on microglia","volume":"101","author":"Perry","year":"1992","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.expneurol.2025.115355_bb0245","doi-asserted-by":"crossref","first-page":"460","DOI":"10.21147\/j.issn.1000-9604.2022.05.07","article-title":"Myeloid checkpoints for cancer immunotherapy","volume":"34","author":"Qian","year":"2022","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.expneurol.2025.115355_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104722","article-title":"Defining molecular identity and fates of CNS-border associated macrophages after ischemic stroke in rodents and humans","volume":"137","author":"Rajan","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2025.115355_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2012.06.013","article-title":"Neuromyelitis optica: Aquaporin-4 based pathogenesis mechanisms and new therapies","author":"Ratelade","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.expneurol.2025.115355_bb0260","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.molimm.2014.06.003","article-title":"Inhibitor(s) of the classical complement pathway in mouse serum limit the utility of mice as experimental models of neuromyelitis optica","volume":"62","author":"Ratelade","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.expneurol.2025.115355_bb0265","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis","volume":"130","author":"Roemer","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2025.115355_bb0270","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice","volume":"133","author":"Saadoun","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2025.115355_bb0275","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ana.22686","article-title":"Neutrophil protease inhibition reduces neuromyelitis optica\u2013immunoglobulin G\u2013induced damage in mouse brain","volume":"71","author":"Saadoun","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2025.115355_bb0280","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/neup.12235","article-title":"TMEM119 marks a subset of microglia in the human brain","volume":"36","author":"Satoh","year":"2016","journal-title":"Neuropathology"},{"key":"10.1016\/j.expneurol.2025.115355_bb0285","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.immuni.2023.01.008","article-title":"Direct activation of microglia by \u03b2-glucosylceramide causes phagocytosis of neurons that exacerbates Gaucher disease","volume":"56","author":"Shimizu","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.expneurol.2025.115355_bb0290","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001076","article-title":"New BBB model reveals that IL-6 blockade suppressed the BBB disorder, preventing onset of NMOSD","volume":"8","author":"Takeshita","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.expneurol.2025.115355_bb0295","doi-asserted-by":"crossref","DOI":"10.1093\/jb\/mvp001","article-title":"Protein tyrosine kinase, Syk: a key player in phagocytic cells","author":"Tohyama","year":"2009","journal-title":"J. Biochem."},{"issue":"10","key":"10.1016\/j.expneurol.2025.115355_bb0300","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2025.115355_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2025.115355_bb0310","doi-asserted-by":"crossref","first-page":"12370","DOI":"10.1074\/jbc.M116.721258","article-title":"Induction of siglec-1 by endotoxin tolerance suppresses the innate immune response by promoting TGF-\u03b21 production","volume":"291","author":"Wu","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2025.115355_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2018.12.002","article-title":"Neuromyelitis optica spectrum disorder: pathogenesis, treatment, and experimental models","author":"Wu","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.expneurol.2025.115355_bb0320","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/rheumatology\/ket342","article-title":"Increased expression of Siglec-1 on peripheral blood monocytes and its role in mononuclear cell reactivity to autoantigen in rheumatoid arthritis","volume":"53","author":"Xiong","year":"2014","journal-title":"Rheumatology (United Kingdom)"},{"key":"10.1016\/j.expneurol.2025.115355_bb0325","doi-asserted-by":"crossref","DOI":"10.1111\/cns.13899","article-title":"Phagocytic microglia and macrophages in brain injury and repair","author":"Yu","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.expneurol.2025.115355_bb0330","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1172\/JCI67554","article-title":"Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica","volume":"123","author":"Zhang","year":"2013","journal-title":"J. Clin. Invest."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625002195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625002195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:22:08Z","timestamp":1778876528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488625002195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":65,"alternative-id":["S0014488625002195"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115355","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenic role of CD169+ macrophages in neuronal loss and motor decline in NMO mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115355"}}